MiR-125b targets BCL3 and suppresses ovarian cancer proliferation

Int J Cancer. 2011 May 15;128(10):2274-83. doi: 10.1002/ijc.25575.

Abstract

Micro-RNAs (miRNAs) important for post-transcriptional gene expression as negative regulators are endogenous 21- to 23-nucleotide noncoding RNAs. Many miRNAs are expressed in ovarian cancer (OC). In this study, we reported that miR-125b was underexpressed in human OC specimens. Ectopic expression of miR-125b in OC cells induced cell cycle arrest and led to reduction in proliferation and clonal formation. This inhibitory effect on OC cell growth was mediated by miR-125b inhibition of the translation of an mRNA encoding a proto-oncogene, BCL3. Furthermore, expression of miR-125b suppressed the tumor formation generated by injecting OC cells in nude mice. Our results suggest that aberrantly expressed miR-125b may contribute to OC development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Cell Lymphoma 3 Protein
  • Base Sequence
  • Blotting, Western
  • Cell Cycle
  • Cell Line, Tumor
  • Cell Proliferation*
  • DNA Primers
  • Female
  • Gene Expression Profiling
  • Humans
  • Mice
  • Mice, Nude
  • MicroRNAs / genetics*
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / pathology*
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factors / genetics*
  • Up-Regulation

Substances

  • B-Cell Lymphoma 3 Protein
  • BCL3 protein, human
  • Bcl3 protein, mouse
  • DNA Primers
  • MAS1 protein, human
  • MIRN125 microRNA, human
  • MicroRNAs
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Transcription Factors